{"abstract": "The alliance seeks to build on the results of an experimental treatment that trains a person\u2019s immune system to kill cancer cells.", "web_url": "https://www.nytimes.com/2012/08/06/business/novartis-and-penn-unite-on-anticancer-approach.html", "snippet": "The alliance seeks to build on the results of an experimental treatment that trains a person\u2019s immune system to kill cancer cells.", "lead_paragraph": "The drugmaker Novartis and the University of Pennsylvania announced a research and licensing agreement early Monday that aims to bring to market a new approach to fighting cancer that has shown promising results in early trials.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis and Penn Unite on New Anticancer Path", "kicker": null, "content_kicker": null, "print_headline": "Novartis and Penn Unite On New Anticancer Path", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Cancer", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Novartis AG", "rank": 3, "major": "N"}, {"name": "organizations", "value": "University of Pennsylvania", "rank": 4, "major": "N"}, {"name": "subject", "value": "Colleges and Universities", "rank": 5, "major": "N"}], "pub_date": "2012-08-06T05:15:02+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/01263e02-7b13-58f2-9531-cd230c957f2a", "word_count": 424, "uri": "nyt://article/01263e02-7b13-58f2-9531-cd230c957f2a"}